Benefit of Latanoprostene Bunod (Vyzulta) for Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Cohort Study in Taiwan

Abstract Introduction Topical prostaglandin analogs (PGAs) are used to treat glaucoma and provide significant reductions in intraocular pressure (IOP). This study evaluated the efficacy and safety of latanoprostene bunod 0.024% (LBN; Vyzulta®) in Taiwanese patients with glaucoma who were switched fr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chen-Jui Chiu, Ying-Ying Chen, Yi-Shan Chen
Format:	Artigo
Idioma:	Inglês
Publicat:	Adis, Springer Healthcare 2026-04-01
Col·lecció:	Ophthalmology and Therapy
Matèries:	Latanoprostene bunod (LBN) Vyzulta Glaucoma Intraocular pressure (IOP) Prostaglandin (PG)
Accés en línia:	https://doi.org/10.1007/s40123-026-01367-4
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!